Loading...
Header Logo
Keywords
Last Name
Institution

Dr Robert Ridley

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Nwaka S, Ochem A, Besson D, Ramirez B, Fakorede F, Botros S, Inyang U, Mgone C, Adae-Mensah I, Konde V, Nyasse B, Okole B, Guantai A, Loots G, Atadja P, Ndumbe P, Sanou I, Olesen O, Ridley R, Ilunga T. Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continent. BMC Int Health Hum Rights. 2012 Jul 27; 12:11. PMID: 22838941.
      View in: PubMed
    2. Nwaka S, Besson D, Ramirez B, Maes L, Matheeussen A, Bickle Q, Mansour NR, Yousif F, Townson S, Gokool S, Cho-Ngwa F, Samje M, Misra-Bhattacharya S, Murthy PK, Fakorede F, Paris JM, Yeates C, Ridley R, Van Voorhis WC, Geary T. Integrated dataset of screening hits against multiple neglected disease pathogens. PLoS Negl Trop Dis. 2011 Dec; 5(12):e1412. PMID: 22247786.
      View in: PubMed
    3. Remme JH, Adam T, Becerra-Posada F, D'Arcangues C, Devlin M, Gardner C, Ghaffar A, Hombach J, Kengeya JF, Mbewu A, Mbizvo MT, Mirza Z, Pang T, Ridley RG, Zicker F, Terry RF. Defining research to improve health systems. PLoS Med. 2010 Nov 16; 7(11):e1001000. PMID: 21124816.
      View in: PubMed
    4. Nwaka S, Ilunga TB, Da Silva JS, Rial Verde E, Hackley D, De Vré R, Mboya-Okeyo T, Ridley RG. Developing ANDI: a novel approach to health product R&D in Africa. PLoS Med. 2010 Jun 29; 7(6):e1000293. PMID: 20613865.
      View in: PubMed
    5. Horstick O, Sommerfeld J, Kroeger A, Ridley R. Operational research in low-income countries. Lancet Infect Dis. 2010 Jun; 10(6):369-70. PMID: 20510275.
      View in: PubMed
    6. Nwaka S, Ramirez B, Brun R, Maes L, Douglas F, Ridley R. Advancing drug innovation for neglected diseases-criteria for lead progression. PLoS Negl Trop Dis. 2009 Aug 25; 3(8):e440. PMID: 19707561.
      View in: PubMed
    7. Mboya-Okeyo T, Ridley RG, Nwaka S. The African Network for Drugs and Diagnostics Innovation. Lancet. 2009 May 02; 373(9674):1507-8. PMID: 19410700.
      View in: PubMed
    8. Ridley RG, Ndumbe P, Korte R. Two years after the Fourth External Review: TDR moves forward with a new vision and strategy. PLoS Negl Trop Dis. 2008; 2(11):e307. PMID: 19030228.
      View in: PubMed
    9. Ridley RG, Fletcher ER. Making a difference: 30 years of TDR. Nat Rev Microbiol. 2008 05; 6(5):401-7. PMID: 18414503.
      View in: PubMed
    10. Ridley RG, Kita K. Helminth drug initiative. Expert Opin Drug Discov. 2007 Oct; 2(s1):S1. PMID: 23489028.
      View in: PubMed
    11. Ridley R. Applying science to the diseases of poverty. Bull World Health Organ. 2007 Jul; 85(7):509-10. PMID: 17768498.
      View in: PubMed
    12. Morel CM, Acharya T, Broun D, Dangi A, Elias C, Ganguly NK, Gardner CA, Gupta RK, Haycock J, Heher AD, Hotez PJ, Kettler HE, Keusch GT, Krattiger AF, Kreutz FT, Lall S, Lee K, Mahoney R, Martinez-Palomo A, Mashelkar RA, Matlin SA, Mzimba M, Oehler J, Ridley RG, Senanayake P, Singer P, Yun M. Health innovation networks to help developing countries address neglected diseases. Science. 2005 Jul 15; 309(5733):401-4. PMID: 16020723.
      View in: PubMed
    13. Pagnoni F, Kengeya-Kayondo J, Ridley R, Were W, Nafo-Traoré F, Namboze J, Sirima S. Artemisinin-based combination treatment in home-based management of malaria. Trop Med Int Health. 2005 Jun; 10(6):621-2. PMID: 15941428.
      View in: PubMed
    14. Ridley RG. Research on infectious diseases requires better coordination. Nat Med. 2004 Dec; 10(12 Suppl):S137-40. PMID: 15577932.
      View in: PubMed
    15. Ridley R, Toure Y. Winning the drugs war. Nature. 2004 Aug 19; 430(7002):942-3. PMID: 15318240.
      View in: PubMed
    16. Ridley RG, O'Connell D. A knowledgeable partnership. Nat Rev Microbiol. 2004 Apr; 2(4):267. PMID: 15077608.
      View in: PubMed
    17. Nwaka S, Ridley RG. Virtual drug discovery and development for neglected diseases through public-private partnerships. Nat Rev Drug Discov. 2003 Nov; 2(11):919-28. PMID: 14668812.
      View in: PubMed
    18. Ridley RG. Malaria: to kill a parasite. Nature. 2003 Aug 21; 424(6951):887-9. PMID: 12931167.
      View in: PubMed
    19. Ridley RG. Product R&D for neglected diseases. Twenty-seven years of WHO/TDR experiences with public-private partnerships. EMBO Rep. 2003 Jun; 4 Spec No:S43-6. PMID: 12789406.
      View in: PubMed
    20. Olliaro PL, Ridley RG, Engel J, Sindermann H, Bryceson AD. Miltefosine in visceral leishmaniasis. Lancet Infect Dis. 2003 Feb; 3(2):70. PMID: 12560189.
      View in: PubMed
    21. Ridley RG. Chemotherapeutic hope on the horizon for Plasmodium vivax malaria? Proc Natl Acad Sci U S A. 2002 Oct 15; 99(21):13362-4. PMID: 12374849.
      View in: PubMed
    22. Remme JH, Blas E, Chitsulo L, Desjeux PM, Engers HD, Kanyok TP, Kengeya Kayondo JF, Kioy DW, Kumaraswami V, Lazdins JK, Nunn PP, Oduola A, Ridley RG, Toure YT, Zicker F, Morel CM. Strategic emphases for tropical diseases research: a TDR perspective. Trends Parasitol. 2002 Oct; 18(10):421-6. PMID: 12377584.
      View in: PubMed
    23. Remme JH, Blas E, Chitsulo L, Desjeux PM, Engers HD, Kanyok TP, Kayondo JF, Kioy DW, Kumaraswami V, Lazdins JK, Nunn PP, Oduola A, Ridley RG, Toure YT, Zicker F, Morel CM. Strategic emphases for tropical diseases research: a TDR perspective. Trends Microbiol. 2002 Oct; 10(10):435-40. PMID: 12377547.
      View in: PubMed
    24. Ridley RG. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature. 2002 Feb 07; 415(6872):686-93. PMID: 11832957.
      View in: PubMed
    25. Ridley RG. Introduction. Antimalarial drug resistance: ramifications, explanations and challenges. Microbes Infect. 2002 Feb; 4(2):155-6. PMID: 11880046.
      View in: PubMed
    26. Ridley RG. Robert G Ridley--realising the potential of public-private partnerships. Interview by Pam Das. Lancet Infect Dis. 2002 Jan; 2(1):54-9. PMID: 11892497.
      View in: PubMed
    27. Ridley RG. Putting the partnership into public-private partnerships. Bull World Health Organ. 2001; 79(8):694. PMID: 11545324.
      View in: PubMed
    28. Ridley RG, Lob-Levyt J, Sachs J, Johns D, Evans T, Bale HE, Quick JD, Orbinski J. Round table. A role for public-private partnerships in controlling neglected diseases? Bull World Health Organ. 2001; 79(8):771-7. PMID: 11545335.
      View in: PubMed
    29. Kurosawa Y, Dorn A, Kitsuji-Shirane M, Shimada H, Satoh T, Matile H, Hofheinz W, Masciadri R, Kansy M, Ridley RG. Hematin polymerization assay as a high-throughput screen for identification of new antimalarial pharmacophores. Antimicrob Agents Chemother. 2000 Oct; 44(10):2638-44. PMID: 10991837.
      View in: PubMed
    30. Alzeer J, Chollet J, Heinze-Krauss I, Hubschwerlen C, Matile H, Ridley RG. Phenyl beta-methoxyacrylates: a new antimalarial pharmacophore. J Med Chem. 2000 Feb 24; 43(4):560-8. PMID: 10691682.
      View in: PubMed
    31. Vial HJ, Traore M, Fairlamb AH, Ridley RG. Renewed strategies for drug development against parasitic diseases. Parasitol Today. 1999 Oct; 15(10):393-4. PMID: 10481147.
      View in: PubMed
    32. Ridley RG. Planting the seeds of new antimalarial drugs. Science. 1999 Sep 03; 285(5433):1502-3. PMID: 10498534.
      View in: PubMed
    33. Vippagunta SR, Dorn A, Bubendorf A, Ridley RG, Vennerstrom JL. Deferoxamine: stimulation of hematin polymerization and antagonism of its inhibition by chloroquine. Biochem Pharmacol. 1999 Sep 01; 58(5):817-24. PMID: 10449192.
      View in: PubMed
    34. Craig AG, Waters AP, Ridley RG. Malaria genome project task force: a post-genomic agenda for functional analysis. Parasitol Today. 1999 Jun; 15(6):211-4. PMID: 10366823.
      View in: PubMed
    35. Vennerstrom JL, Nuzum EO, Miller RE, Dorn A, Gerena L, Dande PA, Ellis WY, Ridley RG, Milhous WK. 8-Aminoquinolines active against blood stage Plasmodium falciparum in vitro inhibit hematin polymerization. Antimicrob Agents Chemother. 1999 Mar; 43(3):598-602. PMID: 10049273.
      View in: PubMed
    36. Vennerstrom JL, Ager AL, Dorn A, Andersen SL, Gerena L, Ridley RG, Milhous WK. Bisquinolines. 2. Antimalarial N,N-bis(7-chloroquinolin-4-yl)heteroalkanediamines. J Med Chem. 1998 Oct 22; 41(22):4360-4. PMID: 9784111.
      View in: PubMed
    37. Ridley RG. Planting new targets for antiparasitic drugs. Nat Med. 1998 Aug; 4(8):894-5. PMID: 9701236.
      View in: PubMed
    38. Bray PG, Mungthin M, Ridley RG, Ward SA. Access to hematin: the basis of chloroquine resistance. Mol Pharmacol. 1998 Jul; 54(1):170-9. PMID: 9658203.
      View in: PubMed
    39. Ridley RG. Malaria: dissecting chloroquine resistance. Curr Biol. 1998 May 07; 8(10):R346-9. PMID: 9601634.
      View in: PubMed
    40. Ridley RG. Plasmodium: drug discovery and development--an industrial perspective. Exp Parasitol. 1997 Nov; 87(3):293-304. PMID: 9371097.
      View in: PubMed
    41. Ridley RG, Dorn A, Vippagunta SR, Vennerstrom JL. Haematin (haem) polymerization and its inhibition by quinoline antimalarials. Ann Trop Med Parasitol. 1997 Jul; 91(5):559-66. PMID: 9329993.
      View in: PubMed
    42. Ridley RG, Matile H, Jaquet C, Dorn A, Hofheinz W, Leupin W, Masciadri R, Theil FP, Richter WF, Girometta MA, Guenzi A, Urwyler H, Gocke E, Potthast JM, Csato M, Thomas A, Peters W. Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737. Antimicrob Agents Chemother. 1997 Mar; 41(3):677-86. PMID: 9056013.
      View in: PubMed
    43. Ridley RG, Hofheinz W, Matile H, Jaquet C, Dorn A, Masciadri R, Jolidon S, Richter WF, Guenzi A, Girometta MA, Urwyler H, Huber W, Thaithong S, Peters W. 4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother. 1996 Aug; 40(8):1846-54. PMID: 8843292.
      View in: PubMed
    44. Ridley RG. Haemozoin formation in malaria parasites: is there a haem polymerase? Trends Microbiol. 1996 Jul; 4(7):253-4. PMID: 8829330.
      View in: PubMed
    45. Thaithong S, Chan SW, Songsomboon S, Wilairat P, Seesod N, Sueblinwong T, Goman M, Ridley R, Beale G. Pyrimethamine resistant mutations in Plasmodium falciparum. Mol Biochem Parasitol. 1992 Jun; 52(2):149-57. PMID: 1620155.
      View in: PubMed
    Ridley's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description